149 related articles for article (PubMed ID: 30768227)
1. Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome).
Cernichiaro-Espinosa LA; Patel NA; Bauer MS; Negron CI; Fallas B; Pogrebniak A; Berrocal AM
Ophthalmic Surg Lasers Imaging Retina; 2019 Feb; 50(2):e33-e37. PubMed ID: 30768227
[TBL] [Abstract][Full Text] [Related]
2. SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD.
Ho M; Yip WWK; Chan VCK; Young AL
Retin Cases Brief Rep; 2017 Fall; 11(4):352-355. PubMed ID: 27472514
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for incontinentia pigmenti.
Shah PK; Bachu S; Narendran V; Kalpana N; David J; Srinivas CR
J Pediatr Ophthalmol Strabismus; 2013 Oct; 50 Online():e52-4. PubMed ID: 25313552
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of ranibizumab in severe retinopathy of incontinentia pigmenti.
Ni Y; Huang X; Ruan L; Xue K; Yu J; Peng J; Zhao P
J AAPOS; 2018 Aug; 22(4):325-327.e3. PubMed ID: 29630932
[TBL] [Abstract][Full Text] [Related]
5. Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report.
Kunzmann S; Ngyuen T; Stahl A; Walz JM; Nentwich MM; Speer CP; Ruf K
BMC Pediatr; 2019 Oct; 19(1):353. PubMed ID: 31615465
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of retinopathy of incontinentia pigmenti by anti-vascular endothelial growth factor].
Wang X; Liang JH
Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):294-301. PubMed ID: 30982292
[No Abstract] [Full Text] [Related]
7. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions.
Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M
Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion.
Fong KC; Barry C; McAllister IL
Clin Exp Ophthalmol; 2009 Jul; 37(5):485-9. PubMed ID: 19624345
[TBL] [Abstract][Full Text] [Related]
9. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
10. Extended Follow-up of Treated and Untreated Retinopathy in Incontinentia Pigmenti: Analysis of Peripheral Vascular Changes and Incidence of Retinal Detachment.
Chen CJ; Han IC; Tian J; Muñoz B; Goldberg MF
JAMA Ophthalmol; 2015 May; 133(5):542-8. PubMed ID: 25695859
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice.
Khan M; Wai KM; Silva FQ; Srivastava S; Ehlers JP; Rachitskaya A; Babiuch A; Deasy R; Kaiser PK; Schachat AP; Yuan A; Singh RP
Ophthalmic Surg Lasers Imaging Retina; 2017 Jun; 48(6):465-472. PubMed ID: 28613352
[TBL] [Abstract][Full Text] [Related]
12. Non-contact ultra-widefield retinal imaging and fundus fluorescein angiography of an infant with incontinentia pigmenti without sedation in an ophthalmic office setting.
Patel CK; Fung TH; Muqit MM; Mordant DJ; Geh V
J AAPOS; 2013 Jun; 17(3):309-11. PubMed ID: 23607978
[TBL] [Abstract][Full Text] [Related]
13. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein angiographic findings in a male infant with incontinentia pigmenti.
DeVetten G; Ells A
J AAPOS; 2007 Oct; 11(5):511-2. PubMed ID: 17498989
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab.
Hajrasouliha AR; Garcia-Gonzales JM; Shapiro MJ; Yoon H; Blair MP
Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):255-259. PubMed ID: 28297039
[TBL] [Abstract][Full Text] [Related]
16. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
17. Rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography.
Brar M; Grewal DS; Sharma M; Grewal SPS
Indian J Ophthalmol; 2018 Apr; 66(4):572. PubMed ID: 29582824
[No Abstract] [Full Text] [Related]
18. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
19. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
[TBL] [Abstract][Full Text] [Related]
20. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up.
Arevalo JF; Lasave AF; Wu L; Maia M; Diaz-Llopis M; Alezzandrini AA; Brito M;
Retina; 2017 Feb; 37(2):334-343. PubMed ID: 27429384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
